Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michelle Elliott

23PUBLICATIONS
60CO-AUTHORS
HaematologyGene and molecular therapyFoetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

Sort by Publication Date:
|Mar 28, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales.

Lucas T Go, Lewis T Go, Michelle A Elliott

|Dec 13, 2024
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

Naseema Gangat, Azeem Elbeih, Nour Ghosoun

|Jun 13, 2024
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.

Naseema Gangat, Amritpal Singh, Rimal Ilyas

|Dec 15, 2023
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

Omer Karrar, Maymona Abdelmagid, Masooma Rana

|Sep 21, 2023
Mast cell cytomorphology and treatment outcome in mast cell leukemia.

Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali

|Sep 09, 2023
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.

Animesh Pardanani, Ayalew Tefferi, Aref Al-Kali

Pageof 4

Frequent Collaborators

20 joint publications

Ayalew Tefferi

17 joint publications

Kebede H Begna

15 joint publications

Naseema Gangat

13 joint publications

Animesh Pardanani

12 joint publications

Mrinal S Patnaik

9 joint publications

Mark R Litzow

6 joint publications

Aref Al-Kali

5 joint publications

Mithun V Shah

4 joint publications

Talha Badar

4 joint publications

Dong Chen

Frequent Collaborators

20 joint publications

Ayalew Tefferi

17 joint publications

Kebede H Begna

15 joint publications

Naseema Gangat

13 joint publications

Animesh Pardanani

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

31.0K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.3K
See more related videos

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

31.0K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.3K
See more related videos